AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 112 filers reported holding AVIDITY BIOSCIENCES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $851,181 | -43.9% | 133,414 | -2.6% | 0.11% | -44.2% |
| Q2 2023 | $1,518,310 | -28.5% | 136,908 | -1.1% | 0.20% | -32.5% |
| Q1 2023 | $2,124,747 | -30.8% | 138,420 | 0.0% | 0.29% | -35.0% |
| Q4 2022 | $3,071,540 | -12.8% | 138,420 | -35.8% | 0.45% | -30.9% |
| Q3 2022 | $3,523,000 | +12.4% | 215,750 | 0.0% | 0.65% | -17.5% |
| Q2 2022 | $3,134,000 | -98.5% | 215,750 | -94.6% | 0.79% | -73.6% |
| Q1 2022 | $215,750,000 | +4107.3% | 3,984,902 | +1747.0% | 2.99% | +108.4% |
| Q4 2021 | $5,128,000 | -9.3% | 215,750 | -6.0% | 1.43% | -10.1% |
| Q3 2021 | $5,654,000 | -0.3% | 229,595 | 0.0% | 1.59% | -14.6% |
| Q2 2021 | $5,673,000 | -36.6% | 229,595 | -44.0% | 1.87% | -43.1% |
| Q1 2021 | $8,946,000 | -33.1% | 410,181 | -21.8% | 3.28% | -33.0% |
| Q4 2020 | $13,378,000 | – | 524,239 | – | 4.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 907,567 | $22,353,000 | 19.68% |
| 5AM Venture Management, LLC | 555,555 | $13,683,000 | 2.78% |
| Octagon Capital Advisors LP | 446,641 | $11,001,000 | 2.71% |
| EcoR1 Capital, LLC | 2,759,505 | $67,967,000 | 2.36% |
| Cormorant Asset Management, LP | 2,162,115 | $53,253,000 | 2.16% |
| Asymmetry Capital Management, L.P. | 126,116 | $3,106,000 | 1.87% |
| RTW INVESTMENTS, LP | 4,795,000 | $118,101,000 | 1.78% |
| Aaron Wealth Advisors LLC | 229,595 | $5,654,000 | 1.59% |
| Altium Capital Management LP | 225,000 | $5,542,000 | 1.45% |
| Boxer Capital, LLC | 1,121,327 | $27,618,000 | 0.96% |